CN Patent

CN109422765B — C类β-内酰胺酶抑制剂及其制备方法和应用

Assigned to Shenzhen Research Institute HKPU · Expires 2020-08-28 · 6y expired

What this patent protects

本发明提供了一种C类β‑内酰胺酶抑制剂，所述C类β‑内酰胺酶抑制剂为6α‑(1R‑羟基‑3(2‑噻吩‑基)丙基)青霉素酸，具有如下式1所示结构，

USPTO Abstract

本发明提供了一种C类β‑内酰胺酶抑制剂，所述C类β‑内酰胺酶抑制剂为6α‑(1R‑羟基‑3(2‑噻吩‑基)丙基)青霉素酸，具有如下式1所示结构，

Drugs covered by this patent

durlobactam-sodium (DURLOBACTAM SODIUM)

Patent Metadata

Patent number: CN109422765B
Jurisdiction: CN
Classification: —
Expires: 2020-08-28
Drug substance claim: No
Drug product claim: No
Assignee: Shenzhen Research Institute HKPU
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.